These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31438629)

  • 1. Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota.
    Lorenzo D
    Microorganisms; 2019 Aug; 7(9):. PubMed ID: 31438629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance: a rundown of a global crisis.
    Aslam B; Wang W; Arshad MI; Khurshid M; Muzammil S; Rasool MH; Nisar MA; Alvi RF; Aslam MA; Qamar MU; Salamat MKF; Baloch Z
    Infect Drug Resist; 2018; 11():1645-1658. PubMed ID: 30349322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbes of the human eye: Microbiome, antimicrobial resistance and biofilm formation.
    Ranjith K; Sharma S; Shivaji S
    Exp Eye Res; 2021 Apr; 205():108476. PubMed ID: 33549582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.
    Sanfilippo CM; Morrissey I; Janes R; Morris TW
    Curr Eye Res; 2016 May; 41(5):581-9. PubMed ID: 26200173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical chloramphenicol for eye infections.
    Lam RF; Lai JS; Ng JS; Rao SK; Law RW; Lam DS
    Hong Kong Med J; 2002 Feb; 8(1):44-7. PubMed ID: 11861993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
    McDonald M; Blondeau JM
    J Cataract Refract Surg; 2010 Sep; 36(9):1588-98. PubMed ID: 20692574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.
    Bertino JS
    Clin Ophthalmol; 2009; 3():507-21. PubMed ID: 19789660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence properties of multidrug resistant ocular isolates of Acinetobacter baumannii.
    Talreja D; Muraleedharan C; Gunathilaka G; Zhang Y; Kaye KS; Walia SK; Kumar A
    Curr Eye Res; 2014 Jul; 39(7):695-704. PubMed ID: 24502411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloramphenicol use and susceptibility patterns in Israel: a national survey.
    Nitzan O; Kennes Y; Colodner R; Saliba W; EdelsteinI H; Raz R; Chazan B
    Isr Med Assoc J; 2015 Jan; 17(1):27-31. PubMed ID: 25739173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in ocular bacterial infections: an integrative review of ophthalmic chloramphenicol.
    Bale BI; Elebesunu EE; Manikavasagar P; Agwuna FO; Ogunkola IO; Sow AU; Lucero-Prisno DE
    Trop Med Health; 2023 Mar; 51(1):15. PubMed ID: 36895063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is chloramphenicol making a comeback?
    Nitzan O; Suponitzky U; Kennes Y; Chazan B; Raul R; Colodner R
    Isr Med Assoc J; 2010 Jun; 12(6):371-4. PubMed ID: 20928993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms.
    Zacchino SA; Butassi E; Cordisco E; Svetaz LA
    Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain- and antibiotic-specific differences.
    Singh R; Sahore S; Kaur P; Rani A; Ray P
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27402781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections.
    Bowler PG
    J Wound Care; 2018 May; 27(5):273-277. PubMed ID: 29738295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
    Segreti J; Jones RN; Bertino JS
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):3-11. PubMed ID: 21999341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study.
    Haas W; Pillar CM; Torres M; Morris TW; Sahm DF
    Am J Ophthalmol; 2011 Oct; 152(4):567-574.e3. PubMed ID: 21652021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities to topical antibiotics of bacteria isolated from the surface of clinically symptomatic eyes.
    Egger SF; Ruckhofer J; Alzner E; Hell M; Hitzl W; Huber-Spitzy V; Grabner G
    Ophthalmic Res; 2001; 33(2):117-20. PubMed ID: 11244359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools.
    Di Luca M; Maccari G; Nifosì R
    Pathog Dis; 2014 Apr; 70(3):257-70. PubMed ID: 24515391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in ophthalmic antimicrobial utilization pattern in Bahrain between 1993 and 2000: a resurgence of chloramphenicol?
    Jassim Al Khaja KA; Sequeira RR; Mathur VS
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):36-41. PubMed ID: 12564744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.